Etomidate recalls
The FDA has published 2 recalls involving Etomidate since 2014. The latest was reported on 27 Mar 2019. Most were for potency & assay. Agila Specialties Private has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Mar 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why etomidate is recalled
Companies
By year
All etomidate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Etomidate Injection, USP 20 mg/ (2mg/mL) Single-Dose Vial recalled | Heritage Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | etomidate injection, USP, 2 mg/mL recalled by Agila Specialties Private | Agila Specialties Private | Particulate Matter | Nationwide |
Should you stop taking Etomidate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.